Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Macrogenics Inc’s stock clocked out at $1.78, up 8.54% from its previous closing price of $1.64. In other words, the price has increased by $8.54 from its previous closing price. On the day, 25.58 million shares were traded.
Ratios:
To gain a deeper understanding of MGNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.28. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.41.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 15 ’25 when Smith Beth Ann sold 423 shares for $2.56 per share. The transaction valued at 1,083 led to the insider holds 9,532 shares of the business.
Stock Price History:
Over the past 52 weeks, MGNX has reached a high of $5.77, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is 21.55%, while the 200-Day Moving Average is calculated to be -35.27%.
Shares Statistics:
A total of 63.09M shares are outstanding, with a floating share count of 57.94M. Insiders hold about 8.16% of the company’s shares, while institutions hold 80.39% stake in the company.
